SUBKUTAN ADMINISTRATION in English translation

• subcutaneous administration

Examples of using Subkutan administration in Danish and their translations into English

Subkutan administration efter indsætning i Reco- Pen som foreskrevet.
Subcutaneous use after insertion into the Reco-Pen as directed.

Ved subkutan administration bør injektionsstedet veksles ved hver administration..
When given subcutaneously, the site of injection should be rotated with each administration.

Subkutan administration bør foretages i overarm,
Subcutaneous administration should be in the upper arms,

Subkutan administration er at foretrække i de fleste tilfælde.
The subcutaneous route is preferred in most cases.

Den observerede forskel skyldes sandsynligvis langsom absorption fra injektionsstedet efter subkutan administration.
The observed difference is likely due to slow absorption from the injection site following subcutaneous administration.

Den endelige halveringstid efter subkutan administration bestemmes af absorptionshastigheden fra det subkutane væv.
The terminal half-life after subcutaneous administration is determined by the rate of absorption from the subcutaneous tissue.

Den absolutte biotilgængelighed af rekombinant humant væksthormon efter subkutan administration er cirka 80.
The absolute bioavailability of recombinant human growth hormone after subcutaneous administration is about 80.

Efter subkutan administration af efalizumab toppede koncentrationerne i plasma efter 1- 2 dage.
After subcutaneous administration of efalizumab peak plasma concentrations are reached after 1- 2 days.

Den tilsyneladende fordelingsvolumen hos patienter efter subkutan administration var 78 ± 32 ml/ kg.
The apparent volume of distribution in patients following subcutaneous administration was 78± 32 ml/ kg.

Efter subkutan administration af difloxacin nås det maksimale plasmaniveau 3, 1 time efter dosering.
After subcutaneous administration of difloxacin peak plasma levels of 1.4 -1.9 µg/ ml are achieved in 3.1 hours post dosing.

Alvorlige allergiske reaktioner er ikke rapporteret under de kliniske forsøg ved subkutan administration af Humira.
Serious allergic adverse reactions have not been reported with subcutaneous administration of Humira during clinical trials.

Efter subkutan administration ses dosisproportionalitet i serumkoncentration(maksimumkoncentration, absorptionsomfang) inden for det terapeutiske dosisområde.
Dose proportionality in serum concentrations(maximum concentration, extent of absorption) is observed after subcutaneous administration in the therapeutic dose range.

Visse populationer Somapropins absolutte biotilgængelighed synes at være ens hos mænd og kvinder efter subkutan administration.
Sub-populations The absolute bioavailability of somatropin seems to be similar in males and females following subcutaneous administration.

Subkutan administration med en dosis på 3 x 250 IE/ kg legemsvægt pr. uge.
The solution is administered subcutaneously at a dose of 3 x 250 IU/ kg b. w. per week.

Den absolutte biotilgængelighed efter subkutan administration af 90 mg enfuvirtid i abdomen var 84, 3 ± 15.
The absolute bioavailability after subcutaneous administration of enfuvirtide 90 mg in the abdomen was 84.3± 15.5.

Efter subkutan administration af degarelix i akutte, subakutte og kroniske toksicitetsforsøg hos rotter og aber sås ikke målorgantoksicitet.
No target organ toxicity was observed from acute, subacute and chronic toxicity studies in rats and monkeys following subcutaneous administration of degarelix.

AUC( 0- ∞) var næsten det samme hos børn og voksne med kronisk nyresvigt(CRF) efter subkutan administration.
AUC(0-∞) was similar between adult and paediatric patients with CRF following subcutaneous administration.

Udskillelse Azacitidin udskilles hurtigt fra plasma med en gennemsnitlig elimineringshalveringstid(t½) efter subkutan administration på 41 ± 8 minutter.
Excretion Azacitidine is cleared rapidly from plasma with a mean elimination half-life(t½) after subcutaneous administration of 41± 8 minutes.

Den terminale halveringstid efter subkutan administration hos patienter er længere med et middeltal på 160 timer 84 til 353 timer.
The terminal half-life after subcutaneous administration in patients is longer with a mean value of 160 hours 84 to 353 hours.

voksne med kronisk nyresvigt(CRF) efter både intravenøs og subkutan administration.
paediatric patients with CRF following both intravenous and subcutaneous administration.